ArticleScientific reports2025
Impact of the CYP27B1 p.R389H mutation on protein stability and function: implications for multiple sclerosis pathogenesis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The CYP27B1 gene is crucial for vitamin D metabolism, which regulates immune functions. Mutations such as p.R389H may disrupt protein stability and function, potentially influencing diseases like multiple sclerosis (MS). This study examines the structural and functional consequences of the CYP27B1 p.R389H (rs118204009) mutation and its potential role in MS pathogenesis. The CYP27B1 sequence (UniProt ID: O15528) was retrieved, and its 3D structure was predicted using AlphaFold. The p.R389H mutation was introduced via PyMOL to assess structural and functional changes. Structural validation was conducted using ERRAT2, VERIFY3D, and Ramachandran plot analysis. Stability was analyzed using I-Mutant, Mcsm, DDGun, DynaMut, and Mupro, while functional impact was predicted with PolyPhen-2, PhD-SNP, SNPs&GO, and SIFT. Evolutionary conservation was assessed with ConSurf. AlphaFold predicted a high-confidence 3D structure of CYP27B1 (pLDDT > 90), highlighting the p.R389H mutation, where arginine is substituted by histidine. Structural validation showed minimal disruption, while phylogenetic analysis identified the mutation's location in a conserved region, highlighting its potential functional significance. Stability analysis predicted a destabilizing effect (ΔΔG values ranging from - 0.3 to - 2.038 kcal/mol), and functional impact tools classified the mutation as "probably damaging" and disease-associated. Molecular dynamics simulations further supported these results by revealing altered structural behavior of the mutant protein, with reduced flexibility and stability. Computational findings suggested p.R389H (rs118204009) mutation could impair the role of CYP27B1 in vitamin D metabolism, potentially contributing to MS pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.